PRVA
Privia Health Group, Inc.23.81
-0.53-2.18%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
2.93BP/E (TTM)
170.07Basic EPS (TTM)
0.14Dividend Yield
0%Recent Filings
8-K
8-K
ACO savings surge 32%
Privia Health's ACOs generated $233.1 million in shared savings under the 2024 Medicare Shared Savings Program, up 32% from 2023, by managing $2.5 billion in benchmark spend for 194,700 beneficiaries through 3,280 providers. This strong performance, with a 9.3% aggregate savings rate and costs 8% below median ACOs, prompted a preliminary hike in 2025 Adjusted EBITDA guidance to $113-$116 million. Success stems from physician-led tools. Regulatory compliance remains a key risk.
10-Q
Q2 FY2025 results
Privia Health's Q2 revenue climbed 23.4% year-over-year to $521.2M, fueled by 20.2% growth in fee-for-service patient care and 33.8% in capitated revenue from expanded attributed lives, while shared savings surged 50.7% on better value-based care performance. Operating income dipped 34.6% to $3.3M amid higher provider expenses, yet net income attributable to common stockholders held at $0.02 per diluted share, consistent with last year and reconciled to 128.4M weighted shares. The Arizona acquisition closed April 2025 for $89.1M net cash, adding $30.6M goodwill and $64.4M payer/physician intangibles amortized over 17.3 years on average. Cash stood at $390.1M with full $125M revolver availability and no debt outstanding. Free cash flow not disclosed in the 10-Q. Regulatory compliance remains a key risk in this heavily regulated industry.
8-K
Q2 revenue up 23.4%
Privia Health crushed Q2 2025 with revenue jumping 23.4% to $521.2 million, driven by 13.8% more implemented providers and 18.5% higher practice collections at $862.9 million. Adjusted EBITDA soared 31.6% to $29.0 million, fueled by platform efficiencies, while the Arizona IMS acquisition bolsters expansion. Cash sits at $390.1 million with no debt. Guidance now tops prior highs across key metrics. Regulatory compliance remains a key risk.
8-K
Berberian joins Privia board
Privia Health Group expanded its board to ten directors and appointed Lance Berberian as a Class III director and Audit Committee member, effective July 15, 2025. Berberian, a 30-year technology veteran and former CIO at Labcorp, brings expertise in digital transformation, cybersecurity, and IT governance to bolster Privia's growth in provider networks. His pro-rated initial equity grant totals $200,000 in restricted stock units. This addition sharpens oversight amid scaling operations.
IPO
Website
Employees
Sector
Industry
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
DH
Definitive Healthcare Corp.
2.29-0.01
EVH
Evolent Health, Inc
4.07-0.05
FORA
Forian Inc.
2.14+0.00
LVCE
LIVECARE INC
0.01+0.00
PAXH
PreAxia Health Care Payment Sys
0.22+0.00
PHR
Phreesia, Inc.
16.35-0.35
PIII
P3 Health Partners Inc.
4.59-0.36
PINC
Premier, Inc.
28.26+0.00
TBRG
TruBridge, Inc.
22.25-0.27